Research Article
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea
Table 1
Clinical and biochemical characteristics of participants.
| | Measurement | Controls () | OSA () | value |
| | Age (years) | 55.2 ± 7.5 | 54.6 ± 8.4 | 0.78 | | Women/men | 9/15 | 22/42 | 0.81 | | BMI (kg/m2) | 27.7 ± 2.7 | 27.6 ± 3.4 | 0.92 | | Waist circumference (cm) | 89.0 ± 3.8 | 90.6 ± 4.0 | 0.09 | | TC (mmol/L) | 4.22 ± 0.62 | 4.98 ± 0.55 | <0.01 | | LDL-C (mmol/L) | 2.74 ± 0.42 | 3.19 ± 0.38 | <0.01 | | HDL-C (mmol/L) | 1.24 ± 0.21 | 1.12 ± 0.19 | 0.02 | | TGs (mmol/L) | 2.07 ± 0.23 | 2.18 ± 0.28 | 0.08 | | AHI (events/h) | 3.15 ± 1.04 | 27.09 ± 16.95 | <0.01 | | Mean oxygen saturation (%) | 95.7 ± 1.0 | 89.8 ± 3.3 | <0.01 | | Lowest oxygen saturation (%) | 87.8 ± 2.5 | 73.4 ± 8.5 | <0.01 | | Oxygen saturation < 90% (%) | 0.40 ± 0.15 | 23.39 ± 4.67 | <0.01 | | Fasting glucose (mmol/L) | 5.22 ± 0.72 | 5.60 ± 0.95 | 0.08 | | Fasting insulin (mlU/L) | 18.5 ± 7.2 | 22.9 ± 7.8 | 0.02 | | HOMA-IR | 2.37 ± 0.89 | 2.95 ± 0.92 | <0.01 | | AEA (nmol/L) | 2.53 ± 0.63 | 3.09 ± 0.77 | <0.01 | | 1/2-AG (nmol/L) | 34.3 ± 7.7 | 40.8 ± 5.7 | <0.01 |
|
|
Data is presented as mean ± SD. Differences were considered significant when .
|
